课题基金 / 基金详情

A PHASE-I/II STUDY OF IMC-A12 IN CHILDREN WITH RELAPSED/ REFACTORY SOLID TUMORS"

A PHASE-I/II STUDY OF IMC-A12 IN CHILDREN WITH RELAPSED/ REFACTORY SOLID TUMORS"
IMC-A12 在复发/难治性实体瘤儿童中的 I/II 期研究"
批准号：
7958528
负责人：
Charles T Roberts
金额：
$3.45万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
项目状态：
已结题
起止时间：
2009-08-04 至 2010-04-30
来源：
https://reporter.nih.gov/project-details/7958528
关键词：
Antibody TherapyChildComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantInstitutionInsulin-Like-Growth Factor I ReceptorPatientsPhasePrimatesRelapseResearchResearch PersonnelResourcesSolid NeoplasmSourceUnited States National Institutes of Healthreceptor

项目摘要

项目成果

Charles T Roberts的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This project will determine IGF-I receptor protein levels in PBMC's from patients before and after anti-IGF-I receptor protein levels in PBMC's from patients before and after anti-IGF-IR antibody therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
YR 50 PROJ- ROBERTS PRIMATE ISLET
MOLECULAR MECHANISMS OF HUMAN AND MURINE BETA CELL PROLIFERATION & REGENERATION
HERSTATIN: A NOVEL CANCER THERAPEUTIC
HERSTATIN: A NOVEL CANCER THERAPEUTIC
海外基金